Global Sponsors
Sponsors
Resetting the pharma agenda for a post- covid-19 world
Through the lens of Covid-19 and the industry response to the crisis, the 2nd edition of FT US Pharma and Biotech Summit will provide a fresh perspective on the crucial issues affecting the pharma and biotech industries. Senior industry leaders will share their insights, ideas and expertise on topics such as pharma pricing and politics, the expansion of real-world evidence and the opportunities and challenges of unconventional partnerships and collaborations across the new healthcare landscape.
Premier digital events supported by the world's best journalism.
FT Live events keep you connected and informed in an uncertain and constantly changing world. Using leading digital technology, we have now taken our content, global audience reach and engagement to a new level through a series of unmissable virtual events. Our compelling programmes, chaired by respected FT journalists, feature the most senior and thought-provoking decision-makers in business, finance and politics, all accessible from your office or home.
Why attend
Gain insights into the healthcare reforms
being proposed in and beyond the US Presidential election and how they might affect pharma pricing and risk
Hear what Covid-19 has taught us
about the challenge of accelerating drug development
Delve deeper
into the emerging best practice of Real World Evidence (RWE) and its impact on pharma business
Discuss the challenges and opportunities
of unconventional partnerships in pharma and the myth and reality of pharma’s digital divide
Discover the latest developments
in gene editing and have your say on where we should draw the line between risk and opportunity
Debate
whether gene and cell therapies can be commercially successful given manufacturing and reimbursement complexities
World-class business leaders and speakers including:
"The US Pharma and Biotech Summit was engaging and educational. The sessions highlighted the complexities that we have in the US healthcare system and the various view points that we should all consider."
VP, Strategic Data and Digital, US Oncology, Novartis
Moderated by
Industry related reading
Key factors and trends shaping the US pharma industry.
Key factors and trends shaping the US pharma industry.
Key factors and trends shaping the US pharma industry.
Other Events
Global Pharmaceutical and Biotechnology Conference
Women at the Top
Weekend Festival